Your search returned 3 results.

Results
	1.	Phase II dose-ranging trial of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients intolerant of or resistant to ganciclovir (ACTG protocol 093). AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. [electronic resource] by Jacobson, M A Wulfsohn, M Feinberg, J E Davis, R Power, M Owens, S Causey, D Heath-Chiozzi, M E Murphy, R L Cheung, T W Producer: 19940726 In: AIDS (London, England) vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadir. [electronic resource] by Kempf, D J Rode, R A Xu, Y Sun, E Heath-Chiozzi, M E Valdes, J Japour, A J Danner, S Boucher, C Molla, A Leonard, J M Producer: 19980608 In: AIDS (London, England) vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Effect of highly active antiretroviral therapy and thymic transplantation on immunoreconstitution in HIV infection. [electronic resource] by Markert, M L Hicks, C B Bartlett, J A Harmon, J L Hale, L P Greenberg, M L Ferrari, G Ottinger, J Boeck, A Kloster, A L McLaughlin, T M Bleich, K B Ungerleider, R M Lyerly, H K Wilkinson, W E Rousseau, F S Heath-Chiozzi, M E Leonard, J M Haase, A T Shaw, G M Bucy, R P Douek, D C Koup, R A Haynes, B F Bolognesi, D P Weinhold, K J Producer: 20000607 In: AIDS research and human retroviruses vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)